Business Wire

Morinaga Milk Expands Lactoferrin Production Capacity in German Subsidiary “MILEI GmbH”

28.10.2020 08:52:00 EET | Business Wire | Press release

Share

Morinaga Milk Industry Co., Ltd. (TOKYO: 2264) (hereafter, “Morinaga Milk”) hereby announces that its subsidiary MILEI GmbH (hereafter, “MILEI”), which has the largest share* of the global market in terms of production volume of the functional ingredient lactoferrin, will increase more than double its production capacity with the aim to enhance its lactoferrin production.
* According to data for 2019 released by Absolute Reports

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201027006307/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Powdered lactoferrin (Photo: Morinaga Milk)

1. Overview

(1) Location: Kemptener Strasse 91, 88299 Leutkirch, Germany
(2) Product manufactured: Lactoferrin
(3) Total investment: EUR 15,000,000 (approx. JPY 1.8 billion*) * Assuming an exchange rate of 120 yen to one euro
(4) Production capacity: Approx. 170 tons (more than double that of fiscal 2019)
(5) Launch of operations: April 2021 (planned)

2. Background and purpose

As a functional ingredient for infant formula, supplements and other foods, the demand for lactoferrin has been growing particularly in Western countries and Asia.
Considering the increasing attention towards health and nutrition, the demand for lactoferrin as a functional ingredient with health value is expected to grow over the long term globally.
Morinaga Milk Group considers lactoferrin as an important functional ingredient to support people’s health and nutrition worldwide and has been conducting fundamental research and seeking commercial applications for over six decades.
Morinaga Milk Group is aiming to increase the sales of its own lactoferrin-related products with expanding production capacity in MILEI, and will flexibly respond to the long-term increasing demand of lactoferrin.
Having the largest production share of lactoferrin, Morinaga Milk Group will increase the production of MILEI and contribute to the well-being of people.

3. Effect on financial results

The investment will not affect financial results for the fiscal year ending March 31, 2021.

[Reference information]

MILEI GmbH

MILEI is based in the southern German city of Leutkirch, where its production facilities are located.
Founded in 1972, MILEI has a history of almost five decades since its start of production in 1975. MILEI offers lactoferrin, whey protein concentrate, lactose and other dairy ingredients mainly in Europe and Asia. Many companies, including global food manufacturers, use MILEI’s ingredients for infant formula, sports nutrition and others. Under the global strategy of Morinaga Milk, MILEI plays an important role supporting production and sales of ingredients for infant formula, supplements and others.

Lactoferrin

Present in most exocrine secretions such as breast milk and saliva of humans and other mammals, lactoferrin is a component with a wide range of physiological functions. The high amount of lactoferrin found in human breast milk, especially in colostrum, is considered to offer important and protective benefits to newborns.
Discovered by Danish scientists in 1939, lactoferrin as a remarkable functional ingredient, has been intensively researched by scientists worldwide, as shown by the increasing number of the studies in the graph (Figure 1). Paying high attention to the fact that lactoferrin is highly abundant in colostrum, Morinaga Milk has been focusing its research efforts on lactoferrin over the long term to develop infant formula that closely resembles breast milk. Since its initial publication of a research paper on lactoferrin in 1963, Morinaga Milk has been reporting its benefits through academic forums, conferences and publications.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

International Division, Morinaga Milk Industry Co., Ltd.
Yoshihiko Ushida
Tamami Shibata
TEL: +81-3-3798-0152
E-mail: interntl@morinagamilk.co.jp
https://www.morinagamilk.co.jp/english/
https://www.milei.de (MILEI GmbH Website)

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ZincFive Expands Nickel-Zinc Technology into In-Rack Backup and AI Dynamic Power Solutions28.9.2026 15:05:00 EEST | Press release

ZincFive®, the leader in nickel-zinc (NiZn) battery-based solutions for immediate power applications, today announced its expansion into in-rack energy storage with the development of Battery Backup Unit (BBU) and AI Dynamic Power Module (DPM) solutions designed to address the evolving energy storage requirements of AI data centers. As AI drives higher rack power densities and increasingly dynamic workloads, data center power architectures are evolving to manage both traditional backup requirements and rapid, repeated changes in power demand. These transient loads can place significant stress on electrical infrastructure, creating a growing need for power solutions closer to the rack that can respond quickly, safely, and reliably. Today’s rack-level technologies often require tradeoffs between energy capacity and dynamic power response. Traditional BBUs are primarily designed to provide backup runtime, while capacitor-based systems offer rapid response but limited energy duration and s

Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 3 AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus28.9.2026 15:00:00 EEST | Press release

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced the primary endpoint was met in the Phase 3 portion of the AZURE-1 study evaluating brelovitug, an investigational fully human monoclonal antibody that binds to hepatitis B surface antigen (HBsAg), for the treatment of chronic hepatitis delta virus (HDV). In addition, 48-week data from the Phase 2b portion of AZURE-1 demonstrated deepening viral suppression, with a greater proportion of patients achieving HDV RNA below the lower limit of quantification (LLOQ, <10 IU/mL) and target not detected (TND), and increased rates of alanine aminotransferase (ALT) normalization. AZURE-1 is one of two pivotal Phase 3 studies intended to form the basis of Mirum’s U.S. registration package for brelovitug. “These results demonstrate the potential of brelovitug as a well-tolerated, convenient, single agent to deliver both deep viral suppression and ALT normalization, with responses that continue to deepen throu

Oscilloquartz and Iridium expand resilient positioning and navigation capabilities with new PNT service integration28.9.2026 15:00:00 EEST | Press release

Oscilloquartz today announced the next phase of its collaboration with Iridium Communications Inc., expanding the range of Iridium® positioning, navigation and timing (PNT) (formerly Iridium Satellite Time and Location® or STL®) capabilities available across its synchronization portfolio. The latest integration brings resilient positioning and navigation alongside trusted timing to a broader range of applications. Building on the companies’ existing collaboration, it strengthens end-to-end, multi-layered assured PNT architectures for critical infrastructure, defense and other GNSS-dependent applications. “Organizations are adopting layered PNT architectures to improve resilience and reduce dependence on any single timing or positioning source,” said Rohit Braggs, VP of PNT at Iridium. “Working with Oscilloquartz extends the reach of Iridium® PNT services, making it easier for customers to deploy resilient, multi-source PNT architectures.“ Expanded support for Iridium® PNT services exte

Mirion Technologies to Host Inaugural Mirion Connect EMEA/APAC Conference in Brussels28.9.2026 15:00:00 EEST | Press release

Mirion Technologies, a leading provider of advanced radiation safety solutions, today announced Mirion Connect 2026 EMEA/APAC, the company’s first regional edition of its Mirion Connect conference for Europe, the Middle East, Africa and Asia-Pacific region. The event will take place September 29 – October 1, 2026, in Brussels, Belgium. Mirion Connect, an event hosted in the United States for 40 years, brings together nuclear and radiation safety professionals from around the world for a week of expert-led presentations, open-forum discussions, hands-on technical training and targeted breakout sessions. Expanding to Europe, the event is designed to give attendees direct access to the latest developments in radiation detection, measurement and safety technologies, alongside practical guidance they can apply immediately in their own operations. The conference theme — Bound by our history, inspired by the future we shape together — is based upon deep industry partnerships and unites attend

Xceedance Reports 35-50% Efficiency Gains in Insurance Operations Through AI Orchestration28.9.2026 15:00:00 EEST | Press release

Xceedance said today that AI orchestration is producing measurable efficiency gains in live insurance operations, delivered through Orchestrated Intelligence, its operating model, and IAN, its agent studio for insurance. In agency and broker operations, processes moved onto IAN delivered around 35% efficiency improvement from the point of go-live. As these implementations have matured, some are now approaching 50%. Xceedance is seeing the same pattern in underwriting support for excess and surplus lines carriers. The company is also deploying AI at scale in claims third-party administration (TPA) operations, where the volume of repeatable work is large. A significant portion of gains comes from Xceedance teammates continuously refining AI-enabled workflows — correcting output, resolving the exceptions AI cannot handle, and incorporating those learnings into workflows and agent configurations. As processes mature, a greater proportion of routine work can be completed automatically, allo

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye